Spain
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
21.29%
|
Dec. 31, 2023 | USD 66.91 | -1.44% |
|
Spain |
|
2 |
6.33%
|
Dec. 31, 2023 | USD 9.88 | -1.22% |
|
Spain |
|
3 |
2.85%
|
Dec. 31, 2023 | USD 2.66 | -0.99% |
|
Spain |
|
4 |
0.33%
|
Dec. 31, 2023 | USD 93.72 | -2.32% |
|
Spain |
|
5 |
0.28%
|
Dec. 31, 2023 | USD 8.39 | -2.40% |
|
Spain |
|
6 |
-1.62%
|
Dec. 31, 2023 | USD 9.60 | -2.49% |
|
Spain |
|
7 |
-3.14%
|
Dec. 31, 2023 | USD 1.47 | -0.60% |
|
Spain |
|
8 |
-7.25%
|
Dec. 31, 2023 | USD 3.60 | -0.03% |
|
Spain |
|
9 |
-16.15%
|
Dec. 31, 2023 | USD 1.82 | -0.09% |
|
Spain |
The Biotechnology company in Spain with the highest Return on Assets (ROA) is Laboratorios Farmaceuticos Rovi, S.A. (MCE: ROVI.MC) at 21.29%.
The Biotechnology company in Spain with the lowest Return on Assets (ROA) is Pangaea Oncology, S.A. (MCE: PANG.MC) at -16.15%.
The top 10 Biotechnology companies in Spain by Return on Assets (ROA) are Laboratorios Farmaceuticos Rovi, S.A., Prim, S.A., Laboratorio Reig Jofre, S.A., Pharma Mar, S.A., Grifols, S.A., Almirall, S.A., Oryzon Genomics S.A., Atrys Health, S.A. and Pangaea Oncology, S.A..
The bottom 10 Biotechnology companies in Spain by Return on Assets (ROA) are Pangaea Oncology, S.A., Atrys Health, S.A., Oryzon Genomics S.A., Almirall, S.A., Grifols, S.A., Pharma Mar, S.A., Laboratorio Reig Jofre, S.A., Prim, S.A. and Laboratorios Farmaceuticos Rovi, S.A..